Diagnostic Value of Changes in Serum Calprotectin Level and Patients' Sputum in Response to Treatment of Cystic Fibrosis Exacerbation in Children

Diagnostic Value of Changes in Serum Calprotectin Level and Patients' Sputum in Response to Treatment of Cystic Fibrosis Exacerbation in Children


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: نعمت بیلان , فریناز امیری کار , سینا رئیسی

کلمات کلیدی: Calprotectin, Cystic fibrosis, Exacerbation, Iran, Therapeutic outcome.

نشریه: 37721 , 5 , 9 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله نعمت بیلان
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات سلامت کودکان
کد مقاله 76241
عنوان فارسی مقاله Diagnostic Value of Changes in Serum Calprotectin Level and Patients' Sputum in Response to Treatment of Cystic Fibrosis Exacerbation in Children
عنوان لاتین مقاله Diagnostic Value of Changes in Serum Calprotectin Level and Patients' Sputum in Response to Treatment of Cystic Fibrosis Exacerbation in Children
ناشر 3
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background Today few studies have focused on using calprotectin as an effective biomarker for monitoring the exacerbation of pulmonary complications in cystic fibrosis (CF). Thus, the present study aimed to assess the diagnostic value of the changes in the calprotectin level of patient's serum and sputum during responding to the therapy of exacerbated CF in children. Materials and Methods: The cross-sectional study was conducted among 21 CF patients, which received required supportive and therapeutic procedures based on the protocol related to pulmonology ward in the Children Medical Research and Training Center of Tabriz University of Medical Sciences. The sputum and serum samples of all patients were collected to evaluate calprotectin level at 1-2 days after starting therapy with routine antibiotics such as cephalosporin and macrolides, and they were again gathered at the end of therapy process. Results: Assessing outcome in 21 patients under study represented complete and partial recovery in 12 (57.2%), and 9 (42.8%) ones, respectively. The mean decrease in calprotectin level in the serum and sputum of the patients was respectively obtained as 40.72 89.08 μg/ml and 99.03 225.94 μg/ml. The calprotectin decrease in serum with the cutoff point of 15.70 μg/ml possessed the sensitivity of 66.7% and specificity of 55.6% in predicting complete recovery outcome; while that of sputum with the cutoff point of 26.20 μg/ml had the sensitivity and specificity of 66.7 and 22.2%, respectively. Conclusion The mean age of participants were 8.61±4.19 years. It can be concluded that serum and sputum calprotectin decrease with cutoff point of 15.70 μg/ml and 26.20 μg/ml, respectively in have high sensitivity for determining response to treatment in cystic fibrosis exacerbation.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
نعمت بیلاناول
فریناز امیری کاردوم
سینا رئیسیسوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
IJP_Volume 9_Issue 5_Pages 13569-13579 (1).pdf1400/04/14387155دانلود